US FDA expands use of Avadel's sleep disorder drug to ages 7 and up
The U.S. Food and Drug Administration has approved Avadel Pharmaceuticals' sleep disorder drug for children aged 7 years and ...
FDA identifies food safety issues at Delta food preparation facility
Passengers on 200 Delta flights were denied in-flight meal service after food safety issues were discovered in the airline's ...
FDA Has Recalled Thousands of Bottles of Antidepressant Duloxetine, Sold Under Brand Name Cymbalta: Here’s Why
The Duloxetine Delayed-Release Capsules' voluntary recall began on Oct. 10 after the FDA deemed the medication the ...
What's with all the listeria in our food?
It has been a very busy year for food recalls in the United States. The U.S. Food and Drug Administration (FDA) and the U.S.
Thousands of bottles of common antidepressant Cymbalta recalled by FDA over cancer-causing chemical
Thousands of bottles of a commonly prescribed antidepressant drug were recalled because they contained a suspected cancer-causing chemical.
California leads the way on regulation of food additives
Food companies exploit a loophole in the FDA’s rules that let them self-determine an additive’s safety, yielding obvious ...
Juice Drinks Recall Update as FDA Sets Risk Level
In an update issued on Tuesday, the FDA classed the recalls as Class II, which is when the "use of or exposure to a violative product may cause temporary or medically reversible adverse health ...
US FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease
The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract ...
Pharmaceutical Technology2h
FDA approves Alvotech and Teva’s SELARSDI for new indications
The FDA has approved a new presentation of Alvotech and Teva’s SELARSDI, for the treatment of ulcerative colitis and Crohn's ...
Double Point to Buy Lumos Pharma for $38M as FDA OKs Lumos Drug Trial
Shares of Lumos Pharma were set to rise after investment firm Double Point Ventures agreed to buy the biopharmaceutical company for $38 million in cash plus potential milestone payments.
BioPharma Dive14h
FDA names Tarver as new head of device center
Michelle Tarver will officially replace longtime CDRH leader Jeff Shuren, who stepped down from the role earlier this year.
Convenience Store News18h
FDA Seizes 3 Million Unauthorized E-Cigarettes in Joint Federal Operation
The Food and Drug Administration, in collaboration with the U.S. Customs and Border Protection (CBP), seized about three ...